These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 856438)

  • 1. Adriamycin cardiomyopathy--risk factors.
    Minow RA; Benjamin RS; Lee ET; Gottlieb JA
    Cancer; 1977 Apr; 39(4):1397-402. PubMed ID: 856438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QRS voltage change with adriamycin administration.
    Minow RA; Benjamin RS; Lee ET; Gottlieb JA
    Cancer Treat Rep; 1978 Jun; 62(6):931-4. PubMed ID: 667870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adriamycin (doxorubicin) cardiotoxicity: a review.
    Chlebowski RT
    West J Med; 1979 Nov; 131(5):364-8. PubMed ID: 394479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrocardiographic changes after adriamycin chemotherapy.
    Ali MK; Soto A; Maroongroge D; Bekheit-Saad S; Buzdar AU; Blumenschein GR; Hortobagyi GN; Tashima CK; Wiseman CL; Shullenberger CC
    Cancer; 1979 Feb; 43(2):465-71. PubMed ID: 421174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congestive heart failure due to adriamycin cardiotoxicity: its natural history in children.
    Goorin AM; Borow KM; Goldman A; Williams RG; Henderson IC; Sallan SE; Cohen H; Jaffe N
    Cancer; 1981 Jun; 47(12):2810-6. PubMed ID: 6942908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cardiotoxicity of adriamycin and daunomycin in children.
    Gilladoga AC; Manuel C; Tan CT; Wollner N; Sternberg SS; Murphy ML
    Cancer; 1976 Feb; 37(2 Suppl):1070-8. PubMed ID: 1253124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Electrocardiogram analysis of adriamycin cardiotoxicity in 160 cases].
    Wang SQ
    Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):71-3. PubMed ID: 1889343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adriamycin-cyclophosphamide and adriamycin-cis-dichloro-diammineplatinum(II) combination chemotherapy in patients with advanced cancer.
    Higby DJ; Wilbur D; Wallace HJ; Henderson ES; Weiss R
    Cancer Treat Rep; 1977 Aug; 61(5):869-73. PubMed ID: 329980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive monitoring of adriamycin cardiotoxicity by "Sphygmo-Recording" of the pulse wave delay (QKd interval).
    Greco FA; Brereton HD; Rodbard D
    Cancer Treat Rep; 1976 Sep; 60(9):1239-45. PubMed ID: 797446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for doxorubicin-induced congestive heart failure.
    Von Hoff DD; Layard MW; Basa P; Davis HL; Von Hoff AL; Rozencweig M; Muggia FM
    Ann Intern Med; 1979 Nov; 91(5):710-7. PubMed ID: 496103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adriamycin cardiotoxicity in children: case reports, literature review, and risk factors.
    Prout MN; Richards MJ; Chung KJ; Joo P; Davis HL
    Cancer; 1977 Jan; 39(1):62-5. PubMed ID: 188540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total 12-Lead QRS Voltage in Patients Having Orthotopic Heart Transplantation for Heart Failure Caused by Adriamycin-Induced Cardiomyopathy.
    Roberts WC; Haque S; Hall SA
    Cardiology; 2018; 141(3):172-175. PubMed ID: 30650419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is the use of adriamycin (doxorubicin) limited by its cardiotoxicity?].
    Reinhardt D; Hofmann V; Martz G
    Schweiz Med Wochenschr; 1985 Apr; 115(16):557-61. PubMed ID: 4001904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy.
    Pein F; Sakiroglu O; Dahan M; Lebidois J; Merlet P; Shamsaldin A; Villain E; de Vathaire F; Sidi D; Hartmann O
    Br J Cancer; 2004 Jul; 91(1):37-44. PubMed ID: 15162142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adriamycin cardiomyopathy in a child with Wilms tumor and liver metastases (author's transl)].
    Stopfkuchen H; Gutjahr P
    Klin Padiatr; 1976 Sep; 188(5):459-63. PubMed ID: 184344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes.
    Buzzoni R; Bonadonna G; Valagussa P; Zambetti M
    J Clin Oncol; 1991 Dec; 9(12):2134-40. PubMed ID: 1960555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with the use of adriamycin in combination with other anticancer agents using a weekly schedule, with particular reference to lack of cardiac toxicity.
    Weiss AJ; Manthel RW
    Cancer; 1977 Nov; 40(5):2046-52. PubMed ID: 336177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adriamycin (NSC-123127) in combination with cyclophosphamide (NSC-26271): a phase I and II evaluation.
    Muggia FM; Perloff M; Chia GA; Reed LJ; Escher GC
    Cancer Chemother Rep; 1974; 58(6):919-26. PubMed ID: 4614899
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination of adriamycin and cyclophosphamide in the treatment of metastatic prostatic carcinoma: a phase II study.
    Izbicki RM; Amer MH; Al-Sarraf M
    Cancer Treat Rep; 1979 Jun; 63(6):999-1001. PubMed ID: 380805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiomyopathy after widely separated courses of adriamycin exacerbated by actinomycin-D and mithramycin.
    Kushner JP; Hansen VL; Hammar SP
    Cancer; 1975 Nov; 36(5):1577-84. PubMed ID: 172214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.